Submit Article
Legal Analysis. Regulatory Intelligence. Jurisprudence.
Search articles, case studies, legal topics...
Singapore

International Healthway Corp Ltd v The Enterprise Fund III Ltd and others [2018] SGHC 246

In International Healthway Corp Ltd v The Enterprise Fund III Ltd and others, the High Court of the Republic of Singapore addressed issues of Companies — Capital, Equity — Estoppel.

300 wpm
0%
Chunk
Theme
Font

Case Details

  • Citation: [2018] SGHC 246
  • Title: International Healthway Corp Ltd v The Enterprise Fund III Ltd and others
  • Court: High Court of the Republic of Singapore
  • Date of Decision: 13 November 2018
  • Judge: Hoo Sheau Peng J
  • Coram: Hoo Sheau Peng J
  • Case Number: Originating Summons No 380 of 2017
  • Parties: International Healthway Corporation Ltd (Plaintiff/Applicant) v The Enterprise Fund III Ltd and others (Defendants/Respondents)
  • Other Parties/Entities: VMF3 Ltd; Value Monetization III Ltd
  • Legal Areas: Companies — Capital; Equity — Estoppel; Equity — Remedies
  • Key Statutory Provisions: Companies Act (Cap 50, 2006 Rev Ed), in particular ss 76(1A)(a)(i) and 76A
  • Statutes Referenced (as per metadata): Companies Act; Distress Act; Government Proceedings Act; M of the Companies Act; New South Wales Act; New South Wales Code; Residential Property Act
  • Appeal Note: The appeal in Civil Appeal No 119 of 2018 was dismissed by the Court of Appeal on 13 September 2019 (see [2019] SGCA 48).
  • Counsel: Lee Eng Beng SC, Chow Chao Wu Jansen, Danitza Hon Cai Xia and Lee Hui Yi (Rajah & Tann Singapore LLP) for the plaintiff; Leo Zhen Wei Lionel, Chng Zi Zhao Joel, Tan Kai Yun, Elizabeth Gan Wan Zhen and Daniel Lee Wai Yong (WongPartnership LLP) for the defendants.

Summary

International Healthway Corp Ltd v The Enterprise Fund III Ltd and others concerned the validity of a structured financing and share acquisition arrangement that, in substance, enabled a Singapore-listed company to obtain its own shares indirectly. The High Court held that the “trust arrangement” through which the shares were held on behalf of the company was void under s 76A(1)(a) of the Companies Act, because it amounted to a company acquiring or purporting to acquire its own shares in contravention of the prohibition in s 76(1A)(a)(i). The court also held that the facility agreement and related security documents were voidable at the company’s option as “related” transactions under s 76A(2).

The company (IHC) had issued a written notice purporting to avoid the relevant contracts and transactions. The court accepted that the avoidance notice was effective for the “related” transactions, with the practical consequence that the lenders/fund managers (the Crest Funds) could not enforce the facility and security arrangements against IHC as contractual obligations. Importantly, the court also recognised that the Crest Funds retained a statutory pathway under s 76A(4) to seek just and equitable relief for any resulting loss or damage.

What Were the Facts of This Case?

IHC (later known as OUE Lippo Healthcare Limited) was a Singapore-incorporated company listed on the Catalist board of the Singapore Exchange. Two substantial shareholders, Fan Kow Hin (“Mr Fan”) and Andrew Aathar (“Mr Aathar”), were closely involved in the negotiations leading to the transactions. Mr Fan was also the Chief Executive Officer of IHC for a period in 2015–2016. The Crest Funds were three funds managed by Crest Capital Asia Fund Management Pte Ltd, a wholly owned subsidiary of Crest Capital Asia Pte Ltd. The investment director, Tan Yang Hwee (“Mr Tan”), acted as the representative of the Crest Funds.

In April 2015, Mr Tan and Mr Aathar discussed the provision of a credit facility to IHC. The email correspondence and the substance of the discussions reflected a concern about imminent short-selling of IHC shares and the need for a standby credit facility of $20m “for use against this activity”. Mr Aathar proposed that the shares be bought and held by the Crest Funds directly, rather than disbursing funds to IHC to pay a broker. This was intended to avoid a circuitous arrangement and to provide additional security for the Crest Funds in respect of any drawdown under the facility.

On 16 April 2015, the parties entered into a facility agreement for the credit facility, which was later superseded by an agreement dated 30 July 2015. The facility was secured by security arrangements executed on 30 July 2015: three deeds of charge by IHC in favour of the Crest Funds over the share capital of IHC’s wholly owned subsidiaries, and two deeds of undertaking by IHC Management Pte Ltd and IHC Management (Australia) Pty Ltd respectively in favour of the Crest Funds. The facility agreement and security documents were therefore not merely ancillary; they were part of a single financing structure.

From April to August 2015, acting on IHC’s instructions given by Mr Aathar, the first defendant, EFIII, executed drawdowns under the standby facility to purchase IHC shares on the open market. These shares were held in the name of EFIII “on behalf of IHC”, described in the judgment as the “trust arrangement”. Across 14 occasions between 16 April 2015 and 24 August 2015, a total of $17,332,081.15 was drawn down to purchase 59,304,800 IHC shares at prices ranging from $0.285 to $0.31 per share.

On 9 September 2015, the SGX issued an announcement advising shareholders and potential investors to exercise caution because its review suggested that more than 60% of the total traded volume of IHC shares in the relevant period appeared to be conducted by a handful of connected individuals. After the SGX advisory, IHC’s share price fell significantly. IHC subsequently defaulted on the standby facility. EFIII issued a letter of demand on 19 October 2015 for arrears of interest charges (“Standby Fees”). On 15 April 2016, the Crest Funds appointed receivers over the charged shares in IHC’s subsidiaries pursuant to the deeds of charge.

In January 2017, an extraordinary general meeting of IHC resulted in the removal of the incumbent board and replacement by a new board. IHC’s position was that only after the new board took control did the contraventions of the Companies Act come to light, and legal action was then commenced. On 8 March 2017, IHC’s solicitors issued a written notice to the Crest Funds asserting that the acquisition by IHC of its own shares contravened s 76(1A)(a)(i) and that, under s 76A(2), both the share acquisitions and the standby facility were voidable at IHC’s option. IHC purported to avoid the transactions by written notice and asserted that the Crest Funds had no contractual claim against IHC under the facility and security agreements.

The Crest Funds disputed this. They denied that the transactions were void or voidable at IHC’s option. IHC then commenced proceedings on 6 April 2017 seeking declarations that: (i) the standby facility, deeds of charge, deeds of undertaking, and the share acquisitions were voidable at IHC’s option under s 76A(2); (ii) the transactions were avoided by the written notice; and (iii) IHC bore no contractual liability to the Crest Funds in relation to the transactions.

The central legal issue was the proper characterisation of the arrangement under the Companies Act. Specifically, the court had to determine whether the open market acquisitions and the trust arrangement amounted to a company acquiring or purporting to acquire its own shares “directly or indirectly” in contravention of s 76(1A)(a)(i). This required the court to look beyond formalities (that the shares were purchased in the name of EFIII) to the substance of the arrangement (that the shares were held on behalf of IHC pursuant to IHC’s instructions).

A second issue concerned the consequences of contravention under s 76A. The court needed to decide whether the relevant contracts and transactions were void under s 76A(1), voidable under s 76A(2), or otherwise affected by the statutory scheme. In particular, the court had to determine whether the standby facility and security documents were “related” transactions within the meaning of s 76A(2), such that they were voidable at the company’s option.

A third issue, reflected in the case’s legal areas, involved equity and remedies—especially the interaction between statutory avoidance and potential bars to rescission, as well as the possibility of estoppel arguments in defiance of statute. While the truncated extract does not set out the full treatment of these points, the case’s framing indicates that the court had to consider whether equitable doctrines could prevent the company from relying on the statutory avoidance regime.

How Did the Court Analyse the Issues?

The court began by setting out the statutory framework. Section 76 of the Companies Act restricts “company financing dealings in its shares”, including share buy-backs, financial assistance for share acquisitions, and lending on security of its shares. For present purposes, the key prohibition was s 76(1A)(a)(i), which provides that, except as otherwise expressly provided, a company shall not, whether directly or indirectly, acquire shares in the company. The court treated this as a substance-focused prohibition, designed to prevent circumvention through indirect mechanisms.

Section 76A then provides the consequences of contraventions. Under s 76A(1), certain contracts or transactions made or entered into in contravention of s 76 are void. However, s 76A(1A) disapplies s 76A(1) for “a disposition of book-entry securities”, subject to the court’s power to order transfer of shares acquired in contravention if satisfied that the disposition would otherwise be void. The court’s analysis therefore required it to determine whether the relevant share acquisitions fell within the “book-entry securities” carve-out, and if not, whether they were void under s 76A(1).

On the facts, the court held that the open market acquisitions were not void by virtue of s 76A(1A). This suggests that, at least for the acquisition events themselves, the statutory carve-out applied. However, the court distinguished the open market acquisitions from the trust arrangement. The trust arrangement—where EFIII held the shares on behalf of IHC—was held to be void under s 76A(1)(a). The court’s reasoning reflects a key analytical move: even if the initial acquisition on the market could be treated as not void due to s 76A(1A), the subsequent holding and beneficial arrangement effectively constituted the company’s indirect acquisition or holding of its own shares, thereby engaging s 76A(1).

Turning to the facility agreement and security agreements, the court held that these were voidable as “related” transactions under s 76A(2). The statutory language makes voidable not only the contravening contracts or transactions, but also contracts or transactions “related to” such contravening transactions. The court treated the standby facility and security documents as functionally connected to the share acquisitions: the facility provided the funds for the purchases, and the security arrangements secured the lenders’ position in relation to the facility. As a result, they were not independent commercial arrangements but part of the same contravening scheme.

The court further accepted that IHC had avoided the “related” transactions by its written notice. This is crucial because s 76A(2) frames avoidance as an option exercisable by the company. The court therefore focused on whether the notice was properly given and whether the transactions fell within the statutory category of voidable “related” transactions. Having found that they did, the court concluded that the avoidance notice was effective, with the consequence that IHC did not owe contractual liability to the Crest Funds in relation to those avoided arrangements.

Although the court decided in favour of IHC, it also recognised that the Crest Funds had recourse to s 76A(4). That provision allows the court, on application, to make orders that are “just and equitable” against the company or any other person in respect of any resulting loss or damage suffered or likely to be suffered by the counterparty. This indicates that the statutory avoidance regime does not necessarily leave the counterparty remediless; rather, it shifts the remedy from contractual enforcement to a court-supervised equitable adjustment under the statute.

Finally, the case’s legal areas indicate that arguments involving equity and estoppel were likely raised. The court’s approach, as reflected in the outcome, suggests that equitable doctrines could not override the statutory consequences expressly provided by s 76A. Where Parliament has prescribed voidness or voidability and a structured remedial scheme, the court is generally reluctant to allow estoppel or other equitable bars to defeat the statutory design. The judgment’s emphasis on the statutory avoidance and the availability of s 76A(4) underscores that the statutory framework is the primary lens through which remedies and fairness are assessed.

What Was the Outcome?

The High Court granted declarations in favour of IHC. It held that the open market acquisitions were not void under s 76A(1A), but that the trust arrangement was void under s 76A(1)(a). It further held that the standby facility and the security agreements (the deeds of charge and deeds of undertaking) were voidable as “related” transactions under s 76A(2), and that IHC had validly avoided those transactions by its written notice.

As a practical effect, IHC was not liable under the avoided facility and security arrangements. However, the court expressly noted that the Crest Funds were not without recourse: they could apply under s 76A(4) for just and equitable orders to address any resulting loss or damage. The appeal was later dismissed by the Court of Appeal on 13 September 2019 (Civil Appeal No 119 of 2018), confirming the High Court’s approach.

Why Does This Case Matter?

This case is significant for corporate finance practitioners and litigators because it demonstrates how Singapore courts will scrutinise share buy-back and share acquisition structures for indirect contraventions of the Companies Act. The decision highlights that formal compliance (eg, shares purchased in the name of a third party or fund vehicle) will not necessarily protect a transaction if the substance is that the company is effectively acquiring or holding its own shares through a structured arrangement.

From a statutory remedies perspective, the case clarifies the operation of s 76A’s layered consequences: certain contraventions may be void, others may be voidable, and some may be carved out for book-entry dispositions. The court’s distinction between the open market acquisitions and the trust arrangement is particularly instructive for drafting and structuring—because it shows that different components of a transaction may attract different statutory consequences.

For lawyers advising counterparties to such arrangements, the judgment also underscores the importance of s 76A(4) as the remedial “safety valve”. While avoidance may strip contractual enforcement, the statutory scheme contemplates that a counterparty may still seek court-ordered relief for loss or damage. Practitioners should therefore consider, early in disputes, how to frame evidence and submissions for a just and equitable order under s 76A(4), rather than relying solely on contractual claims.

Legislation Referenced

  • Companies Act (Cap 50, 2006 Rev Ed), in particular:
    • Section 76(1A)(a)(i)
    • Section 76A(1)
    • Section 76A(1A)
    • Section 76A(2)
    • Section 76A(4)
  • Distress Act
  • Government Proceedings Act
  • “M of the Companies Act” (as referenced in metadata)
  • New South Wales Act
  • New South Wales Code
  • Residential Property Act

Cases Cited

Source Documents

This article analyses [2018] SGHC 246 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.

Written by Sushant Shukla
1.5×

More in

Legal Wires

Legal Wires

Stay ahead of the legal curve. Get expert analysis and regulatory updates natively delivered to your inbox.

Success! Please check your inbox and click the link to confirm your subscription.